Board of Directors

Anders Ekblom
Chairman of the Board
    • Board member since: 2017
    • Independent in relation to the Company and its management: Yes
    • Independent in relation to major shareholders: Yes
    • Holdings in Alligator: 93,172 and 100,000 warrants in program TO 2022/2025 II.
    • Other current positions: Chairman of Atrogi AB, Elypta AB and Xspray Pharma AB. Board member of AnaMar AB and Mereo BioPharma Group plc
    Hans-Peter Ostler
    Vice chairman of the Board
      • Board member since: 2021
      • Independent in relation to the Company and its management: Yes
      • Independent in relation to major shareholders: Yes
      • Holdings in Alligator: 700,000 and 100,000 warrants in program TO 2022/2025 II.
      • Other current positions: Chairman of the Board in Ectin Research AB and Improve Tec Hönö AB, board member of RGNT Electric AB, Hoodin AB, Cinda Pharma, Promore Pharma, InorbitTX, S.P. HMSO AB, Oblique Therapeutics AB and Lennart Ekerholms Stiftelse. Deputy board member in O Mgmt AB.
      Graham Dixon
      Member of the Board
        • Board member since: 2019
        • Independent in relation to the Company and its management: Yes
        • Independent in relation to major shareholders: Yes
        • Other current positions: Chairman of Apaxen BV
        Eva Sjökvist Saers
        Board member
          • Board member since: 2021
          • Independent in relation to the Company and its management: Yes
          • Independent in relation to major shareholders: Yes
          • Holdings in Alligator: 100,000 warrants in program TO 2022/2025 II.
          • Other current positions: Chairman of the board of Dicot AB (publ). Board member of Bluefish Pharmaceuticals AB (publ), IDL Biotech AB (publ), Oxcia AB and Apoex AB. Deputy board member of Brainstorm Aktiebolag.
          Veronica Wallin
          Board member
            • Board member since: 2021
            • Independent in relation to the Company and its management: Yes
            • Independent in relation to major shareholders: Yes
            • Holdings in Alligator: 31,250 shares and 100,000 warrants in program TO 2022/2025 II.
            • Other current positions: Board member for a number of subsidiaries within the Episurf Group
            Staffan Encrantz
            Board member
              • Board member since: 2022
              • Independent in relation to the Company and its management: Yes
              • Independent in relation to major shareholders: No
              • Holdings in Alligator: 55,642,092 shares
              • Other current positions: Chairman of AnaMar AB, Sweden, a company engaged in the research and development of drugs for fibrosis, Koncentra Verkstads AB, Sweden, a contract manufacturing group, Nclear Inc., Atlanta GA, a company working with environmental clean-up, Oxymetal SAS, France a laser and plasma steel cutting business and Sight Sciences Inc., Menlo Park CA, an eye care company developing and selling devices for surgical treatment of glaucoma and dry eye. Board member of Harbour Solutions Ltd, London, England, a dispute funding and insurance business and Chairman of GovX Inc. San Diego, CA an e-commerce company
              Denise Goode
              Board member
                • Board member since: 2022
                • Independent in relation to the Company and its management: Yes
                • Independent in relation to major shareholders: Yes
                • Holdings in Alligator: 100,000 warrants in program TO 2022/2025 II.
                • Other current positions: CEO of QED Life Sciences Limited, a consultancy company advising and supporting the strategic direction of biotech companies and providing business mentoring to CEOs and senior leaders. Board member of Abliva AB (publ) where she is chair of the remuneration committee and a member of the audit committee. VP, Business Development at AnaMar AB. Certified COVID vaccinator for the UK National Health Service.
                Laura von Schantz
                Board member – Employee representative
                  • Board member since: 2017
                  • Independent in relation to the Company and its management: No
                  • Independent in relation to major shareholders: Yes
                  • Holdings in Alligator: 2,626 shares and 77,000 warrants in program TO 2022/2025 I.
                  • Other current positions: None
                  Updated 2022-07-21